Burning Rock’s Multi-Cancer Detection Blood Test Gets FDA Breakthrough Device Designation
Burning Rock announced that its OverC Multi-Cancer Detection Blood Test has been granted Breakthrough Device Designation by the FDA.
Read MorePosted by Andy Lundin | Jan 3, 2023 | Cancer, Diagnostic Technologies |
Burning Rock announced that its OverC Multi-Cancer Detection Blood Test has been granted Breakthrough Device Designation by the FDA.
Read MorePosted by Andy Lundin | Jan 2, 2023 | Colorectal |
Guardant Health unveiled results from a 20,000 patient study evaluating the performance of its blood test for detecting colorectal cancer.
Read MorePosted by Andy Lundin | Dec 30, 2022 | Leukemia |
Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.
Read MorePosted by Chris Wolski | Dec 26, 2022 | Microscopy, Tissue Processing |
The method leverages AI to improve the quality of images opening the possibility for real-time diagnoses during surgery.
Read MorePosted by Chris Wolski | Dec 21, 2022 | Covid 19 |
Findings have revealed an underlying genetic cause for why some children who have had COVID-19 infection develop MIS-C.
Read More